Edesa Biotech, Inc.
EDSANext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for EDSA. That does not mean none is planned.
Get an email about EDSA's next catalysts
Track Edesa Biotech (EDSA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
EDSA Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.57 | FQ end Sep/2026 | Call: tbd
How EDSA's past catalysts played out
Market Overview
Stock performance and key metrics
EB01
Allergic Contact Dermatitis
vilobelimab
Acute Respiratory Distress Syndrome (ARDS)
paridiprubart
Acute Respiratory Distress Syndrome (ARDS)
EB06
Non-Segmental Vitiligo (NSV)
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
EB01 | Phase 2 | Allergic Contact Dermatitis | - | - |
vilobelimab | Phase 2 | Acute Respiratory Distress Syndrome (ARDS) | - | - |
paridiprubart | Phase 2 | Acute Respiratory Distress Syndrome (ARDS) | - | - |
EB06 | Phase 2 | Non-Segmental Vitiligo (NSV) | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Edesa Biotech, Inc.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in Edesa Biotech, Inc.'s (EDSA) pipeline across Phase 2. Its lead program is EB01 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Edesa Biotech, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Edesa Biotech, Inc. (EDSA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track EDSA biotech catalysts?→
Add EDSA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Edesa Biotech, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.